...
首页> 外文期刊>The lancet. Diabetes & endocrinology. >Follicular thyroid cancer and Hurthle cell carcinoma: challenges in diagnosis, treatment, and clinical management
【24h】

Follicular thyroid cancer and Hurthle cell carcinoma: challenges in diagnosis, treatment, and clinical management

机译:卵泡甲状腺癌和呼吸细胞癌:诊断,治疗和临床管理中的挑战

获取原文
获取原文并翻译 | 示例
           

摘要

Follicular thyroid cancer is the second most common differentiated thyroid cancer histological type and has been overshadowed by its more common counterpart-papillary thyroid cancer-despite its unique biological behaviour and less favourable outcomes. In this Review, we comprehensively review the literature on follicular thyroid cancer to provide an evidence-based guide to the management of these tumours, to highlight the lack of evidence behind guideline recommendations, and to identify changes and challenges over the past decades in diagnosis, prognosis, and treatment. We highlight that correct identification of cancer in indeterminate cytological samples is challenging and ultrasonographic features can be misleading. Despite certain unique aspects of follicular thyroid cancer presentation and prognosis, no specific recommendations exist for follicular thyroid cancer and Hurthle cell carcinoma in evidence-based guidelines. Efforts should be made to stimulate additional research in this field.
机译:卵泡甲状腺癌是第二种最常见的分化的甲状腺癌组织学型,并且已经被其更常见的对手 - 乳头状甲状腺癌掩盖 - 尽管其独特的生物学行为和不利的结果。在这篇综述中,我们全面审查了卵泡甲状腺癌的文献,为这些肿瘤的管理提供了基于循证指南,以突出指南建议缺乏证据,并在过去几十年中识别的变化和挑战,预后和治疗。我们强调,在不确定的细胞学样本中正确鉴定癌症是挑战性的,并且超声特征可能是误导性的。尽管有一定的卵泡甲状腺癌介绍和预后的独特方面,但卵泡甲状腺癌和呼吸细胞癌中没有任何特定的建议在基于证据的准则中。应努力刺激该领域的额外研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号